Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New HDAC6 inhibitors identified at Chong Kun Dang Pharmaceutical

Sep. 28, 2021

Neddylation inhibition identified as a means of treating malignant rhabdoid tumors

Sep. 27, 2021

NLRP3 inflammasome inhibitors patented by Cadila Healthcare

Sep. 27, 2021

Japan Tobacco describes new PDHK2 inhibitors

Sep. 27, 2021

OncoNano expands research collaboration with UTSW on novel cancer therapeutics

Sep. 23, 2021

ShanghaiTech University describes IKZF1/IKZF3 degradation inducers

Sep. 23, 2021

Shanghai Zheye Biotechnology patents G12C mutant GTPase KRAS inhibitors

Sep. 23, 2021

Theragnostics and AAA to jointly develop Ga-68 one-step PET radiopharmaceuticals

Sep. 22, 2021

Discovery of novel BRAF dimer inhibitors with promising efficacy

Sep. 22, 2021

Fochon Pharmaceuticals describes CDK2/CDK4/CDK6 inhibitors

Sep. 22, 2021

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...